What the business is, and whether it's a good one at a fair price.
Operates a small pharmaceutical business alongside a residual jewellery trade, with FY26 revenue of Rs. 4.25 crore and a reported EBITDA margin of 42.4 percent. The company, formerly Deep Diamond India Limited, has shifted focus toward health, agro-tourism and investments, and is classified in the Gems, Jewellery and Watches basic industry. A Pharmaceutical Business segment generated Rs. 0.25 crore of revenue and Rs. 0.0524 crore EBIT in the period ended March 2026, while a Jewellery Business segment that was active in earlier quarters showed no revenue in FY26. Other Income contributed Rs. 0.18 crore EBIT in the same period. The biggest expense line is other operating expenses at 17.1 percent of FY26 revenue, with employee costs at 4.4 percent and materials at 0 percent. Recent activity includes a Rs. 19.92 crore cash acquisition of a 6.37 percent stake (90.3 lakh shares at Rs. 22.06 per share) in Leapfrog Engineering Services, an EPCC firm serving oil and gas, pharma, food processing, metals and chemicals. The company also paid Rs. 2.85 crore as advance for about 49,100 sq. mtr. of land in Pune, Maharashtra, earmarked for a naturopathy centre, holistic rejuvenation centre, medicinal plant cultivation and agro-tourism.
Measured from the filed financials, judged against its Gems, Jewellery And Watches peers · as of FY26 — not investment advice
How has the market priced it — with filings on the timeline?
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
How does it stack up on valuation, returns and growth?
Loading peers…
Quarterly & annual P&L, balance sheet, cash flow, ratios and segments.
Loading financials…
Who owns it — and is the promoter stake clean?
Loading shareholding…
Sign up to see the full company file
Governance, sustainability, compliance, earnings calls, presentations, events, reactions and the full filings feed — free with an account.
Answered from Deep Health AI India Limited's filed financials and exchange disclosures
Deep Health AI India Limited is a Consumer Durables company listed on BSE.
Yes. Over the trailing twelve months Deep Health AI India Limited reported a net profit of ₹1 Cr on revenue of ₹4 Cr.
Yes. The dividend yield is 5.49% at the current price. It paid out 127% of its profit as dividend in FY26.
Effectively yes. It holds ₹8 Cr more cash than debt. Debt stands at 0.01× equity.
On trailing P/E, Deep Health AI India Limited ranks 4 of 54 in Gems, Jewellery And Watches — cheaper than 94% of them, against an industry median of 13.3×. This is a position, not a valuation judgement.
On a typical session Deep Health AI India Limited moves 3.61% — that is the median absolute close-to-close move across its last 269 trading days. Announcement days are routinely larger.
Every NSE and BSE filing by Deep Health AI India Limited appears on this page, AI-summarised, alongside the price reaction that followed it. Follow the company to get each new filing on WhatsApp within minutes.
Figures are as last reported and may lag the latest filing. Not investment advice.
